Payers, Manufacturers Await Federal Vaccine Rollout Plan With Chart: How Close Are We to a Coronavirus Vaccine?

As the many COVID-19 vaccines under development barrel toward clinical trials for safety and efficacy (see infographic,below), questions remain about how they will be distributed when they become available. Payers and PBMs will likely play a critical role in vaccine rollout, but what that will entail is not yet clear. In large part, that’s because both the health insurance industry and pharmaceutical manufacturers are waiting on a vaccine distribution plan from the federal government.

According to Anthony Fauci, M.D., head of the National Institute of Allergy and Infectious Diseases, drug manufacturing firms will coordinate closely with the government to distribute vaccine doses.

© 2025 MMIT
Peter Johnson

Peter Johnson

Peter has worked as a journalist since 2011 and has covered health care since 2020. At AIS Health, Peter covers trends in finance, business and policy that affect the health insurance and pharma sectors. For Health Plan Weekly, he covers all aspects of the U.S. health insurance sector, including employer-sponsored insurance, Medicaid managed care, Medicare Advantage and the Affordable Care Act individual marketplaces. In Radar on Drug Benefits, Peter covers the operations of (and conflicts between) pharmacy benefit managers and pharmaceutical manufacturers, with a particular focus on pricing dynamics and market access. Before joining AIS Health, Peter covered transportation, public safety and local government for various outlets in Seattle, his hometown and current place of residence. He graduated with a B.A. from Colby College.

Related Posts

September 26

News Briefs: Sanders Touts PBM Promise in Pushing for Wegovy, Ozempic Price Cut

READ MORE
republican-and-democratic-party
September 26

Would Red or Blue Election Wins Be Better for PBMs? It’s a Tossup

READ MORE
pharmacist
September 26

Satisfaction With PBM Industry Dips to Record Low in 2024

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today